24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting
Crossref DOI link: https://doi.org/10.1186/s12886-017-0451-1
Published Online: 2017-04-27
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vardarinos, Athanasios
Gupta, Nitin
Janjua, Raazia
Iron, Abigail
Empeslidis, Theo
Tsaousis, Konstantinos T.